Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-349
Closed -$233K 127
2022
Q1
$233K Buy
349
+98
+39% +$65.6K 0.01% 122
2021
Q4
$200K Buy
+251
New +$199K 0.01% 90
2015
Q1
Sell
-1,690
Closed -$182K 40
2014
Q4
$182K Sell
1,690
-200
-11% -$20.3K 0.04% 193
2014
Q3
$187K Buy
1,890
+340
+22% +$32K 0.03% 198
2014
Q2
$145K Hold
1,550
0.02% 263
2014
Q1
$145K Sell
1,550
-50
-3% -$4.45K 0.02% 262
2013
Q4
$150K Buy
+1,600
New +$148K 0.02% 248

Other funds holding ASML

Hirtle Callaghan & Co's ASML Position: Q2 2022 in Review

Hirtle Callaghan & Co sold out of ASML (ASML) in Q2 2022, closing a stake of 349 shares — an estimated $233K sold.

Hirtle Callaghan & Co first reported a position in ASML in Q4 2013 and held it in 7 quarters. The position peaked at $233K in Q1 2022. 921 funds tracked by Wall St. Rank hold ASML as of Q2 2022.

  • Hirtle Callaghan & Co reported no remaining ASML position as of Q2 2022 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 349 ASML shares in Q2 2022, an estimated $233K.
  • Hirtle Callaghan & Co first reported a position in ASML in Q4 2013 and held it in 7 quarters.
  • Hirtle Callaghan & Co's ASML position peaked at $233K in Q1 2022.
  • 921 funds tracked by Wall St. Rank held ASML as of Q2 2022.

Based on Hirtle Callaghan & Co's 13F filing for Q2 2022, filed 15 Aug 2022.